H  
    e made the emotional plea to his colleagues: Pass this bill.  
    It might give somebody like my wife a chance to walk, Texas    Representative Drew Springer said through tears late Thursday    at the state Capitol in Austin. Id trade every one of my    bills Ive passed, every single one of them, to get the chance    to hear HB 810.  
    HB 810 is one of    three bills being considered in the Texas Legislature that    would make it easier for sick people to try unproven therapies    at their own risk, and cost. Springers bill would allow    clinics offering unapproved stem cell treatments to treat    patientsin Texas. HB 661 would    permit people with chronic illness to get therapies in    early-stage clinical trials  not just terminally ill patients,    as the states current right-to-try law does. And HB 3236 would    allow companies to charge patients for unproven therapies.  
    advertisement  
    The debate in Texas echoes a national    discussion over how much access patients should have to    experimentaldrugs. For the lawmakers supporting the    measures, the issue is about the ability to make ones own    decisions about health care and not let bureaucracy get in the    way of that. But for stem cell researchers and many patient    advocates, the bills are dangerous; they make it easier for    people to be fleeced or potentially harmed by treatments with    little evidence suggesting that they work, orare safe.  
      With patients demanding experimental drugs, right to try is      becoming the law of the land    
    When patients get desperate, they have a capacity to suspend    disbelief, said Sean Morrison, a stem cell biologist at the    University of Texas Southwestern Medical Center in Dallas.    When offered the opportunity of a therapy they believe in,    even without data and if the chances of benefit are low,    theyll fight for access to that therapy. The problem is there    are fraudulent stem cell clinics that have sprung up to exploit    that.  
    The personal appeal from Springer, whose wife is paralyzed from    the waist down, has worked, at least for now. HB 810 and the    other two billspassed the House    on Friday with no opposition. They have now moved to the    Senate, which only has two weeks to take them up before the    Legislature breaks on May 29 for two years.Governor Greg    Abbott has indicated he supports HB 810.  
    Stem cells hold tremendous promise as therapies, but experts    say they are still experimental and are not ready to be widely    deployed outside regulated and limited trials. Yet clinics    offering unproven, and sometimes dangerous, stem cell    treatments to eager patients     have proliferated around the country in recent years     even without the state law, there    areat least 71    clinics selling unapproved stem cell therapies in Texas    alone.Stem cell scientists fear that the Texas bill would    lend legitimacy to the field, provide false hope to patients,    and even embolden hucksters touting stem cells as miracle cures    for everything from diabetes to multiple sclerosis to spinal    injuries.  
    It may sound like an appealing idea to allow seriously ill    patients accelerated access to experimental therapies, Sally    Temple, the president of the International Society for Stem    Cell Research, wrote to Texas    lawmakers this month. But in the absence of full clinical    testing, these bills will allow snake oil salesmen to sell    unproven and scientifically dubious therapies to desperate    patients.  
        When offered the opportunity of a therapy they believe in,        even without data and if the chances of benefit are low,        theyll fight for access to that therapy.      
          Sean Morrison, stem cell biologist at the University of          Texas Southwestern Medical Center        
    In the letter, Temple also wrote that the bills would cost    more lives than they save and will undermine confidence in    Texas medical system. She cited     the three women who were blinded after receiving stem cell    procedures at a Florida clinic. At least one of the women    thought she was participating in a clinical trial.  
    For the most part, stem cell clinics and their claims are    unchecked. Theyhave largely avoided regulatory scrutiny    because they typically take a patients own stem cells and    inject them back into the person, meaning the cells are    considered minimally manipulated,taken, perhaps,    from belly fat, purified, and injected near the persons knee.    Plus,stem cell clinics typically do not publish data    about their interventions and their patients results, so    outside researchers have not been able to verify even their    supposed successes.  
    If these clinics really did have a cure for something, you    think they would collect systematic data and publish it in a    journal, so people would know, Morrison said.  
    In a phone interview the morning after his speech, Springer, a    Republican who represents a North Texas district, said he    wanted to maintain some level of oversight for stem cell    therapies and that the state attorney generals office or    health department could step in should problems arise. But he    said he leaned toward letting people have treatments they think    can help them, especially because the drug approval process    takes so long.  
      Stem cell clinics hawking unproven therapies sprout up across      US    
    Springers wife was injured in a diving accident when they were    dating and has been in a wheelchair since. He said they stored    cord blood from when one of their children was born 16 years    ago in hopes that the stem cells from that could one day help    his wife. For now, he wants the Texans who head to places like    Panama and China for stem cell therapies to be able to get them    in their home state, under state law.  
    We do have a responsibility not to let every snake oil    salesman come in, Springer said, but when we do have these    rays of hope, we have to make sure theyre available.  
    Springer is only an author of HB 810, not the other two    measures. The lead authors of the other two measures,    Republican Representative Tan Parker for HB 661, and Republican    Representative Kyle Kacal for HB 3236, did not respond to    requests for comment.  
    HB 810 would give some legal recognition to the stem cell    clinics that are already operating in Texas, an indication that    troubles some researchers. Paul Knoepfler, a stem cell    scientist at the University of California, Davis, co-led a    nationwide survey that found Texas has more stem cell clinics    than many other states, but that the businesses were part of a    national pattern. But he said he hasnt seen other states    consider the types of policies Texas is weighing now.  
    The kind of murky status quo that exists now for regulating    stem cell clinics is quite different than there being laws on    the books that explicitly say that what the clinics are doing    is legal at the state level, Knoepfler wrote in an email.  
    A few years ago, in one famous case, a Houston company, Celltex    Therapeutics, moved its treatment    operations to Mexico after a warning from the Food and Drug    Administration. But experts wonder if the FDA would take    such an action again if the bills became law in Texas, even    though the agency would still maintain its authority to do so    under federal law. That concern also stems from the feeling    that the regulation-averse Trump administration wouldnt    endorse such actions, especially because Vice President Mike    Pence is a    proponent of right-to-try measures and Energy Secretary    Rick Perry, the former Texas governor, credits a stem cell    treatment from Celltex for helping relieve his back    problems.  
    Perrys story and Springers emotional testimony highlight the    uphill battle scientists have faced in recent years as    right-to-try laws have been passed around the country. Powerful    personal stories of patients cured by unapproved drugs or who    die before they can get access to an experimental drug have    swayed many lawmakers from both parties.  
    They look at us like were the devil, which pisses me off    because were doing it the right way, said David Bales, the    chairman of Texans for Cures, a stem cell research advocacy    group that opposes the three bills as written.  
    Baless group wants to fund legitimate clinical trials    involving stem cell treatments to help determine in what ways    the cells can help patients. But for now, its top target is    stopping HB 3236, which would open the door to patients paying    for experimental therapies. Virtually all reputable clinical    trials provide experimental treatments to patients at no cost    and ofteneven pay participants for their effort.  
    We dont think that patients in the most vulnerable positions    should pay for an unproven drug, Bales said.  
    Springer, the state representative, said he had not spoken to    the governor about HB 810. But Abbott, who has been paralyzed    from the waist down since a 1984 accident, when a tree branch    fell on him while he was out for a run, tweeted a message of    support to Springer early last Friday.  
    I look forward to signing HB 810, the tweet said.  
    Andrew Joseph can be reached at andrew.joseph@statnews.com    Follow Andrew on Twitter @DrewQJoseph  
      Trending    
          Thousands of men with prostate cancer get risky          treatment        
          Thousands of men with prostate cancer get risky treatment          they dont need. New approaches could curb        
          FDA weighs crackdown that could shut hundreds of stem        
          FDA weighs crackdown that could shut hundreds of stem          cell clinics        
          Meet one of the worlds most groundbreaking scientists.          Hes        
          Meet one of the worlds most groundbreaking scientists.          Hes 34.        
      Recommended    
          Why nabbing former FDA commissioner Robert Califf would          be        
          Why nabbing former FDA commissioner Robert Califf would          be a win for Verily        
          Patients fare worse with older doctors, study finds        
          Patients fare worse with older doctors, study finds        
          Q&A: Bringing oncology discussions to a broader          audience        
          Q&A: Bringing oncology discussions to a broader          audience        
Read more:
Texas leans into unproven stem cell treatments, to the dismay of ... - STAT